Ziegler Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17,804
| Closed | -$281K | – | 410 |
|
|
2023
Q3 | $281K | Sell |
17,804
-110
| -0.6% | -$1.74K | 0.01% | 377 |
|
|
2023
Q2 | $348K | Buy |
17,914
+3,119
| +21% | +$60.6K | 0.01% | 372 |
|
|
2023
Q1 | $420K | Buy |
14,795
+143
| +1% | +$4.06K | 0.02% | 357 |
|
|
2022
Q4 | $428K | Sell |
14,652
-3,618
| -20% | -$106K | 0.02% | 353 |
|
|
2022
Q3 | $483K | Sell |
18,270
-106
| -0.6% | -$2.8K | 0.02% | 348 |
|
|
2022
Q2 | $816K | Buy |
18,376
+6,553
| +55% | +$291K | 0.03% | 322 |
|
|
2022
Q1 | $585K | Hold |
11,823
| – | – | 0.02% | 330 |
|
|
2021
Q4 | $602K | Sell |
11,823
-4,043
| -25% | -$206K | 0.02% | 362 |
|
|
2021
Q3 | $885K | Sell |
15,866
-530
| -3% | -$29.6K | 0.03% | 342 |
|
|
2021
Q2 | $702K | Buy |
+16,396
| New | +$702K | 0.02% | 366 |
|